Streetbeat News

Earnings

CORT

Corcept Therapeutics (NASDAQ:CORT) has received 4 bullish analyst ratings over the past three months. Analysts have set a 12-month price target range of $38.00 to $44.00, with an average target of $40.5. The company's recent financial performance includes a 38.95% revenue growth rate and an 18.74% net margin, although its ROE is below industry averages.

Portfolio Pulse from Benzinga Insights

May 29, 2024 | 1:00 pm

MSTR

Analysts have provided mixed ratings for MicroStrategy (NASDAQ:MSTR) over the past three months, with a majority being bullish. The average 12-month price target has increased by 38.76% to $1769.2. Despite positive analyst sentiment, MicroStrategy faces financial challenges, including declining revenue, low net margins, and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

May 29, 2024 | 1:00 pm

DASH

DLVHF

DROOF

JTKWY

Top food delivery companies like DoorDash, Deliveroo, Just Eat Takeaway, and Delivery Hero have reported over $20 billion in operating losses since going public. These companies are facing a challenging economic environment, leading to a decline in their stock prices. They are now exploring new revenue streams and experiencing industry consolidation.

Portfolio Pulse from Benzinga Neuro

May 29, 2024 | 12:59 pm

CTXR

Citius Pharmaceuticals (NASDAQ: CTXR) will host an investor call on June 3, 2024, to discuss the topline results of its Phase 3 trial for the Mino-Lok antibiotic lock solution.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:47 pm

AAPL

ACLS

DDOG

GLDD

NVO

PLTR

TGNA

TROW

Jim Cramer recommends buying Apple and finds Axcelis Technologies interesting. He is cautious about Palantir and Datadog, prefers Eli Lilly over Novo Nordisk, and sees T. Rowe Price as a bargain. He is neutral on Great Lakes Dredge & Dock and Tegna.

Portfolio Pulse from Avi Kapoor

May 29, 2024 | 12:47 pm

AAL

JBLU

LUV

SAVE

Several airline stocks, including Southwest Airlines, JetBlue Airways, and Spirit Airlines, are trading lower in sympathy with American Airlines, which revised its second-quarter guidance downward. American Airlines lowered its earnings forecast, operating margin guidance, and TRASM expectations, leading to a sector-wide decline.

Portfolio Pulse from Adam Eckert

May 29, 2024 | 12:40 pm

ASTS

CHWY

SYTA

On May 29th, Siyata Mobile, AST SpaceMobile, and Chewy experienced significant stock price increases due to positive news. Siyata Mobile received a large order from the City of Lancaster, AST SpaceMobile announced a partnership with Verizon, and Chewy reported better-than-expected Q1 earnings and a share repurchase program.

Portfolio Pulse from ryanfaloona@benzinga.com

May 29, 2024 | 12:40 pm

AMZN

FANG

TGT

URNM

On CNBC's 'Halftime Report Final Trades,' analysts discussed Amazon, Target, Sprott Uranium Miners ETF, and Diamondback Energy. Amazon's AWS is negotiating a significant investment in Italy. Target reported a sales decline but beat estimates. Diamondback Energy is selling WTG Midstream Holdings in a $3.25 billion deal.

Portfolio Pulse from Avi Kapoor

May 29, 2024 | 12:35 pm

JOYY shares are trading lower following the company's Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:35 pm

BHVN

Biohaven presented significant development and regulatory progress across various therapeutic areas at its 2024 Investor R&D Day. Key highlights include interim data from the Phase 1 study of BHV-1300, advances in ion channel programs, anticipated Phase 3 data for the Myostatin program in SMA, and promising preclinical data for taldefgrobep alfa in weight loss. Additionally, Phase 1 data for BHV-8000 showed safety and target concentration achievement.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 12:33 pm